Researchers from Boston Children's Hospital and MIT took mini-antibodies from alpacas Bryson and Sanchez. Then they shrunk the mini-antibodies into even smaller nanobodies and engineered these nanobodies onto CAR-T cells. During this process,… read more

Keytruda® or pembrolizumab, MSD's (Merck in USA/Canada) monotherapy for metastatic small cell lung cancer (SCLC) has been granted accelerated approval by FDA. Keytruda® is now indicated for metastatic SCLC with disease progression on… read more

Biologics: Drugs of the future Consumers are increasingly turning to biological drugs because of its almost pinpoint accuracy in treating specific diseases, making it possible for patients to enjoy safe and effective treatments… read more

The launch of new, temperature sensitive biologics, increasing regulations, growing cost- pressures are putting more complex demands on the biopharma industry’s high-stakes logistics environment.   This growth can be witnessed in part due… read more

The biologics manufacturing industry has undergone several changes over the past few years starting from the development of better expression systems to modular and flexible manufacturing facilities including the emergence and use of… read more

With biosimilars being already commercially marketed in India and with multiple biosimilars in the Indian market for the same blockbuster drug, it is becoming increasingly important to understand the concerns and strategies relating… read more